Fulminant myocarditis (FM) is a life-threatening inflammatory disease. However, the mechanisms underlying its acute onset are unknown. By dynamic cardiac function measurement, we discovered that the initiation of sudden hemodynamic collapse was on day 4 in the mouse model of FM. Single-cell RNA-sequencing study revealed that healthy cardiomyocytes (CMs) lost their contractile and metabolic function and differentiated into pro-angiogenic and pro-inflammatory CMs. Meanwhile, neutrophils, the most expanded immune cells, exhibited a unique developmental trajectory only after migrating to the heart, where they continuously attracted peripheral neutrophils via Cxcl2/Cxcl3, resulting in the acute accumulation of neutrophils in the heart. Well-diff...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Despite relevant advances made in therapies for cardiovascular diseases (CVDs), they still represent...
Abstract Fulminant myocarditis (FM) is a life-threatening inflammatory disease. However, the mechani...
Aims Viral myocarditis (VM) is an inflammatory pathology of the myocardium triggered by a viral infe...
Aims Viral myocarditis (VM) is an inflammatory pathology of the myocardium triggered by a viral infe...
Aims Viral myocarditis (VM) is an inflammatory pathology of the myocardium triggered by a viral infe...
Aims Viral myocarditis (VM) is an inflammatory pathology of the myocardium triggered by a viral infe...
Myocardial infarction (MI) elicits massive inflammatory leukocyte recruitment to the heart. Here, we...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Despite relevant advances made in therapies for cardiovascular diseases (CVDs), they still represent...
Background: Inflammation is a prominent feature of arrhythmogenic cardiomyopathy (ACM), but whether ...
Despite relevant advances made in therapies for cardiovascular diseases (CVDs), they still represent...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Despite relevant advances made in therapies for cardiovascular diseases (CVDs), they still represent...
Abstract Fulminant myocarditis (FM) is a life-threatening inflammatory disease. However, the mechani...
Aims Viral myocarditis (VM) is an inflammatory pathology of the myocardium triggered by a viral infe...
Aims Viral myocarditis (VM) is an inflammatory pathology of the myocardium triggered by a viral infe...
Aims Viral myocarditis (VM) is an inflammatory pathology of the myocardium triggered by a viral infe...
Aims Viral myocarditis (VM) is an inflammatory pathology of the myocardium triggered by a viral infe...
Myocardial infarction (MI) elicits massive inflammatory leukocyte recruitment to the heart. Here, we...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Despite relevant advances made in therapies for cardiovascular diseases (CVDs), they still represent...
Background: Inflammation is a prominent feature of arrhythmogenic cardiomyopathy (ACM), but whether ...
Despite relevant advances made in therapies for cardiovascular diseases (CVDs), they still represent...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Acute viral myocarditis (VM), characterised by leukocyte infiltration and dysfunction of the heart, ...
Despite relevant advances made in therapies for cardiovascular diseases (CVDs), they still represent...